期刊文献+

非瓣膜性房颤并射血分数保留心衰患者超声心动图指标与NT-proBNP的相关性 被引量:6

Correlation analysis of echocardiographic parameters and NT-proBNP in patients with nonvalvular atrial fibrillation and ejection fraction preserved heart failure
下载PDF
导出
摘要 目的分析非瓣膜性房颤并射血分数保留心衰患者超声心动图指标与N末端脑钠肽前体(NT-proBNP)的相关性,为临床诊断提供依据。方法回顾性分析2011年6月至2019年6月在揭阳市人民医院心内科接受治疗的100例非瓣膜性房颤并射血分数保留心衰患者的临床资料,根据患者的房颤发作情况分为阵发性房颤组43例和持续性房颤组57例,同期选择50例不伴有房颤的射血分数保留心衰者作为对照组。比较三组患者的左房内径、左心房容积指数、二尖瓣舒张早期血流峰速度(E)/二尖瓣环舒张早期运动峰速度(Em)、左心室射血分数(LVEF)、NT-proBNP及肾小球滤过率(eGFR)的差异,并使用Spearman相关性分析法分析NT-proBNP与超声心动图指标及eGFR的相关性。结果持续性房颤组、阵发性房颤组和对照组患者的左房内径[(48.33±6.43) mm、(42.10±2.62) mm、(33.61±5.52) mm]、左心房容积指数[(35.79±3.66) mL/m、(31.28±4.11) mL/m、(26.10±3.02) m L/m]和NT-proBNP [(1 567.23±436.66) pg/mL、(908.62±199.57) pg/mL、(571.94±101.77) pg/mL]比较差异均有统计学意义(P<0.05),且三组间任意两组的上述指标比较差异均有统计学意义(P<0.05);而持续性房颤组、阵发性房颤组和对照组患者在左室舒张末内径、LVEF、E/Em方面比较差异均无统计学意义(P>0.05);Spearman相关性分析结果显示,NT-proBNP与左心房容积指数、左房内径呈正相关(r=0.470,0.626,P<0.05);与左室舒张末内径、LVEF、E/Em、eGFR无相关性(r=0.153,0.095,0.121,P>0.05)。结论非瓣膜性房颤并射血分数保留心衰患者的NT-proBNP水平显著提高,左房内径明显增大,且NT-proBNP与左心房容积指数、左房内径有明显的相关性。 Objective To analyze the correlation between echocardiographic parameters and N-terminal pro-brain natriuretic peptide(NT-proBNP) in patients with nonvalvular atrial fibrillation and ejection fraction preserved heart failure. Methods The clinical data of 100 patients with nonvalvular atrial fibrillation and heart failure with preserved ejection fraction treated in the Department of Cardiology, Jieyang People’s Hospital from June 2011 to June 2019 were retrospectively analyzed. The patients were divided into the paroxysmal atrial fibrillation group(43 cases) and persistent atrial fibrillation group(57 cases) according to the attack of atrial fibrillation. At the same time, 50 patients with diastolic dysfunction without atrial fibrillation were selected as the control group. The differences of left atrial diameter,left atrial volume index, mitral valve early diastolic peak velocity(E)/mitral annular early diastolic peak velocity(Em),left ventricular ejection fraction(LVEF), NT-proBNP and estimated glomerular filtration rate(eGFR) were analyzed, and the correlation between NT-proBNP and echocardiographic indexes and eGFR was analyzed by Spearman correlation analysis. Results There were significant differences in left atrial diameter with(48.33±6.43) mm,(42.10±2.62) mm,(33.61 ± 5.52) mm, left atrial volume index with(35.79 ± 3.66) mL/m,(31.28 ± 4.11) mL/m,(26.10 ± 3.02) mL/m, and NT-proBNP with(1567.23±436.66) pg/mL,(908.62±199.57) pg/mL,(571.94±101.77) pg/mL among persistent atrial fibrillation group, paroxysmal atrial fibrillation group, and control group(all P<0.05);there was no significant difference in left ventricular end diastolic diameter, LVEF and E/Em among persistent atrial fibrillation group, paroxysmal atrial fibrillation group and control group(all P>0.05). Spearman correlation analysis showed that NT-proBNP was positively correlated with left atrial volume index and left atrial diameter(r=0.470, 0.626, P<0.05), but not with left ventricular end diastolic diameter, LVEF, E/Em, e GFR(r=0.153, 0.095, 0.121, P>0.05). Conclusion NT-pro BNP level and left atrial diameter are significantly increased in patients with nonvalvular atrial fibrillation and ejection fraction preserved heart failure, and there is a significant correlation between NT-pro BNP and left atrial volume index and left atrial diameter.
作者 邝鸿生 黄伟鹏 林涌坚 林锐 陈扬波 KUANG Hong-sheng;HUANG Wei-peng;LIN Yong-jian;LIN Rui;CHEN Yang-bo(Department of Cardiology,Jieyang People's Hospital,Jieyang 522000,Guangdong,CHINA)
出处 《海南医学》 CAS 2022年第2期159-162,共4页 Hainan Medical Journal
关键词 非瓣膜性房颤 超声心动图 N末端脑钠肽前体 射血分数 心衰 肾小球滤过率 Nonvalvular atrial fibrillation Echocardiography N-terminal pro-brain natriuretic peptide(NT-proBNP) Ejection fraction Heart failure Estimated glomerular filtration rate(eGFR)
  • 相关文献

参考文献12

二级参考文献68

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会,杨杰孚,张健,韩雅玲.中国心力衰竭诊断和治疗指南2018[J].中华心力衰竭和心肌病杂志(中英文),2018,2(4):196-225. 被引量:830
  • 3Celik T, Iyisoy A, Celik M, et al. C-reactive protein in chronic heart failure:a new predictor of survival[J]. Int J Cardiol, 2009,135(3) : 396-397.
  • 4Farmakis D, Parissis JT, Bistola V, et al. Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failure[J]. Int J Cardiol, 2010,139 ( 1 ) : 75-79.
  • 5Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the european society of cardiology(ESC) [J]. Eur Heart J, 2010,31 ( 19 ) : 2369- 2429.
  • 6Maeder MT, Kaye DM. Heart failure with normal left ventricular eiection fraction[J]. J Am Coll Cardiol,2009, 53(11) :905-918.
  • 7Yamanouchi S, Kudo D, EndoT, et al. BloodN-terminal proBNP as a potential indicator of cardiac preload in pa- tients with high volume load[J]. Tohoku J Exp Med, 2010,221(3) :175-180.
  • 8Sehulz O,Rudolph A, Scheiner S, et al. Influence of acute and chronic myocardial loading conditions, function, struc- tural changes and extracardiac factors on NT-proBNP in asymptomatic patients with preserved ejection fraction [J]. Clin Res Cardiol,2011,100(1) :57-65.
  • 9Partanen N, Husso M, Vuolteenaho O, et al. N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension[J]. J Hum Hypertens,2011,25 (12) :746-751.
  • 10Koeh M, Haastert B, Kohnle M, et al. Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease [J]. Eur J Heart Fail,2012,14(5) :530-539.

共引文献5890

同被引文献63

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部